, Volume 14, Issue 3, pp 267–273 | Cite as

Phospholipase A2-induced lung edema and its mechanism in isolated perfused guinea pig lung

  • Si-Feng Chen
  • Shao-Hua Li
  • Xia Fei
  • Zhong-Li Wu
Original Articles


Lung injury induced by phospholipase A2 (PLA2, 0.046 IU/ml perfusate) was studied in a continuous weighing system of isolated perfused guinea pig lungs. The results revealed that lung weight increased progressively during the 30-min perfusion of PLA2. No change of pulmonary arterial pressure was observed in the same period. Albumin permeability-surface area product, lung index, lung water content, exudate from pleura, and angiotensin-converting-enzyme activity increased significantly at the end of 30 min PLA2 perfusion.p-Bromophenacyl bromide, a PLA2 inhibitor, may block the above changes nearly completely. The effects of inhibitors of cyclooxygenase (indomethacin, IM), lipoxygenase (diethylcarbamaxine, DE), and platelet-activating factor (SRI 63-441) on PLA2-induced lung injury were also studied. We found: (1) PLA2 may induce high permeability lung edema. The role of endothelial injury in the permeability change remains to be further investigated. (2) DE ameliorated lung injury significantly within 10 min of PLA2 treatment but showed no effect after 15 min. IM ameliorated lung injury during the whole experimental period. SRI 63-441 had no effect. It is suggested that PLA2 may damage lung by inducing products of cyclooxy genase and lipoxygenase besides its direct effect.


Indomethacin Lung Injury Permeability Change Pulmonary Arterial Pressure Endothelial Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vadas, P., andW. Pruzanski. 1986. Role of secretory phospholipase A2 in the pathobiology of disease.Lab. Invest. 55:391–404.Google Scholar
  2. 2.
    Kern, D. F., andA.B. Malik. 1985. Microvascular albumin permeability in isolated perfused lung: Effects of EDTA.J. Appl. Physiol. 58:372–375.Google Scholar
  3. 3.
    Li, S.H., andZ.L. Wu. 1986. Photometric micromethod for assay of serum angiotensin converting enzyme.Acad. J. Second Military Med. Univ. 7:437–440.Google Scholar
  4. 4.
    Vadas, P. 1984. Elevated plasma phospholipase A2 levels: Correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.J. Lab. Clin. Med. 104:873–881.Google Scholar
  5. 5.
    Schoder, T., M. Lempinen, E. Kivilaakso, andP. Nikki. 1982. Serum phospholipase A2 and pulmonary changes in acute fulminant pancreatitis.Resuscitation 10:79.Google Scholar
  6. 6.
    Chen, S.F., Z.L. Wu, andZ.Q. Ding. 1989. Phospholipase A2 and its relationship with acute lung injury in canine acute pancreatitis.J. Med. Coll. PLA (English)4:129–134.Google Scholar
  7. 7.
    Ding, Z.Q., Z.L. Wu, andS.F. Chen. 1989. Pulmonary surfactant system defects and their causes in acute canine pancreatitisNatl. Med. J. China 69:360.Google Scholar
  8. 8.
    Seeger, W., andN. Stuttorp. 1985. Calmodulin and the lung arachidonic acid system.In Calmodulin Antagonists and Cellular Physiology. H. Hidada and D.J. Shrone, editors. Academic Press, Orlando. 401–419.Google Scholar
  9. 9.
    Cox, C. P., M. Mojarad, A. Attiah, andS.I. Said. 1984. Platelet-activating factor (PAF) increases pulmonary vascular permeability in awake sheep.Am. Rev. Respir. Dis. 129(suppl.):A334 (abstract).Google Scholar
  10. 10.
    Chang, S.W., C.O. Feddersen, P.M. Henson, andN.F. Voelke. 1987. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.J. Clin. Invest. 79:1498–1509.Google Scholar

Copyright information

© Plenum Publishing Corporation 1990

Authors and Affiliations

  • Si-Feng Chen
    • 1
  • Shao-Hua Li
    • 1
  • Xia Fei
    • 1
  • Zhong-Li Wu
    • 1
  1. 1.Department of PathophysiologySecond Military Medical UniversityShanghaiChina

Personalised recommendations